Drug Shortage Report for HALOPERIDOL LA
Report ID | 56881 |
Drug Identification Number | 02130300 |
Brand name | HALOPERIDOL LA |
Common or Proper name | HALOPERIDOL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HALOPERIDOL |
Strength(s) | 100MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR |
Packaging size | SINGLE 5ML VIAL |
ATC code | N05AD |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-10-05 |
Actual start date | 2018-10-02 |
Estimated end date | 2018-12-19 |
Actual end date | 2018-11-30 |
Shortage status | Resolved |
Updated date | 2018-12-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2018-12-17 | French | Compare |
v12 | 2018-12-17 | English | Compare |
v11 | 2018-11-12 | French | Compare |
v10 | 2018-11-12 | English | Compare |
v9 | 2018-10-03 | French | Compare |
v8 | 2018-10-03 | English | Compare |
v7 | 2018-08-29 | French | Compare |
v6 | 2018-08-29 | English | Compare |
v5 | 2018-08-13 | French | Compare |
v4 | 2018-08-13 | English | Compare |
v3 | 2018-08-01 | English | Compare |
v2 | 2018-07-30 | French | Compare |
v1 | 2018-07-30 | English | Compare |
Showing 1 to 13 of 13